Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
MMSI Transcript
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral5-12
Merit Medical Systems, Inc. (MMSI) Q1 2026 Earnings Call Transcript
Positive5-1
The earnings call summary indicates strong financial performance, with revenue and EPS exceeding guidance. The Q&A highlights positive market expansion, particularly in the breast cancer market, and strong gross margins. The divestiture of low-margin products and strategic focus on high-growth areas are positives. While geopolitical and supply chain issues are noted, they are not seen as materially impactful. The lack of new partnerships or shareholder return plans is offset by optimistic guidance and market opportunities, leading to a positive sentiment prediction for the stock price.
Merit Medical Systems, Inc. (MMSI) Q4 2025 Earnings Call Transcript
Positive2-25
The earnings call reveals solid financial performance with record-high gross margins, strong operating income growth, and positive revenue projections, especially in the cardiovascular and endoscopy segments. Despite some concerns over OEM revenue and cautious Q1 2026 guidance, the company's strategic acquisitions and optimistic long-term outlook for Rhapsody and other products support a positive sentiment. The market cap suggests a moderate reaction, leading to a 2%-8% stock price increase prediction.
Merit Medical Systems, Inc. (MMSI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-13
MMSI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
